$RDNT

A radiology services company supporting more than 225 hospital facilities is expected to join RadNet.

RadNet (RDNT) will acquire ONRAD, adding $190M-$200M in revenue and $60M-$65M in adjusted EBITDA. ONRAD provides radiology services to 225+ hospitals. The deal is expected to close in early 2027, subject to regulatory approval.

Original reporting
Published Oct 26, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$RDNT
Bullish
high confidence
Mentioned
$RDNT
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$RDNTBullishHigh
01

Why it matters

The acquisition creates a third operating segment for RadNet, positioning it as a full‑stack radiology services provider and potentially improving earnings visibility.

02

Market read

First public disclosure of a material M&A deal in the U.S. radiology services space, likely to move RDNT stock.

03

What to watch

Potential regulatory review delays and the need to retain ONRAD's contracted radiologists.

Relevance 8/10Novelty 8/10Timing: today

Background

RadNet (NASDAQ:RDNT) is a national provider of freestanding diagnostic imaging centers and AI‑enabled health‑tech solutions. ONRAD offers teleradiology and in‑hospital staffing services.

Company-level read

Ticker impact

$RDNTBullishHigh confidence
Context

RadNet announced a definitive agreement to acquire ONRAD, adding $190‑200M of revenue and $60‑65M of adjusted EBITDA in the first year.

Expected impact

likely upward pressure as investors price in the revenue and EBITDA boost

Evidence & confidence

Deal size is material for a mid‑cap, adds a high‑margin, capital‑light segment and is the first public disclosure of the transaction.

Market effects

Strengthens the outpatient imaging and radiology services sector by consolidating teleradiology capabilities.

U.S. healthcare services market may see modest uplift as a leading provider expands its footprint.

Limited to U.S. radiology services; no immediate global macro effect.

Counterpoint

Integration risks could delay synergies, and the cash outlay may strain balance‑sheet flexibility.

Key entities

  • RadNet, Inc.

    Acquirer; listed on NASDAQ under RDNT.

  • ONRAD, Inc.

    Target; private radiology services firm.

Related articles

$RDNTHighAI 8/10

Truist reiterates Buy on RadNet stock after ONRAD acquisition

Truist Securities reiterated a Buy rating and $94 price target on RadNet (RDNT) after its $700M acquisition of ONRAD. The deal includes cash, shares, and an earnout. RadNet's stock trades at $73.77, with analysts citing growth potential. The company reported strong Q2 2026 results, raising guidance and prompting price target increases from multiple analysts.

HighAI 9/10

RadNet acquires ONRAD in $355m deal to broaden radiology provision

RadNet agreed to acquire ONRAD for $355m ($350m cash, $5m shares) with a potential $210m earnout. The deal, expected to close in early 2027, aims to expand RadNet's radiology services and address staffing shortages. RadNet plans to integrate ONRAD's teleradiology and staffing services with its AI-based solutions to improve efficiency and patient care. Jefferies analysts called it a 'sound transaction.'

$RDNTHighAI 8/10

Testing & Diagnostics Services Stocks Q2 Results: Benchmarking Guardant Health (NASDAQ:GH)

Guardant Health, RadNet (NASDAQ:RDNT), Labcorp (NYSE:LH), NeoGenomics (NASDAQ:NEO), and Quest (NYSE:DGX) reported Q2 results. RadNet saw 25% revenue growth, beating estimates. Labcorp's revenue grew 5.8%, meeting expectations but underperforming peers. NeoGenomics and Quest both beat estimates with 11.2% and 10.2% revenue growth, respectively. Stocks have risen since reporting.

$RDNTMed

RadNet (RDNT) Posts Record Revenue But Profit Growth Lags

RadNet (RDNT) reported Q2 2026 revenue of $622.7M, up 25% YoY, and raised full-year guidance. Profit growth lagged, with net income falling to $7.5M from $14.5M YoY. Digital Health revenue grew 56.5%, but its EBITDA dropped 27.2%. Hedge fund ownership declined, while short interest remains high at 14.56%.

$ABXMed

Barrick Profit Soars, Nvidia Eyes $500B AI Push, M&A Accelerates

The article reports multiple US corporate updates. Barrick Mining said Q2 profit rose 50% to $1.22B, with revenue up 44% to $5.29B, and agreed with Newmont on a $1.95B cash top-up to expand Nevada Gold Mines. Nvidia is working on a $500B AI financing venture; Intel announced a $15B stock offering. It also covers results for Axsome (revenue +46%), Monday.com, RadNet, NESR, and Camtek.